性感染症（STD）検査の世界市場規模調査＆予測、疾患タイプ別、検査場所別、地域別分析、2022-2029年

性感染症（STD）検査の世界市場は、2021年に約960億6000万米ドルと評価され、予測期間2022-2029年には5.1％以上の健全な成長率で成長すると予測されています。

性感染症（STD）とは、セクシャルコンタクトによって感染者から非感染者に感染する感染症を指します。STDは、細菌とウイルスによって引き起こされます。クラミジア、淋病、単純ヘルペスウイルス、梅毒、ヒトパピローマウイルス（HPV）、ヒト免疫不全ウイルスなどは、STDの一種です。世界の性病の有病率の増加、性病に対する有利な償還政策、主要企業の戦略的取り組みが、市場成長を加速させる主な要因となっています。

世界保健機関（WHO）の推計によると、2020年には、世界で約3億7400万件のSTIの新規症例が報告されています。また、最も流行している感染症はクラミジアで1億2900万件、次いで淋病で8200万件、梅毒で710万件、トリコモナス症で1億5600万件とされています。また、新興国市場におけるヘルスケア・インフラの発展や、STDの蔓延に対する患者の意識の高まりは、予測期間中に同市場に有利な成長見通しをもたらすと思われます。しかし、検査機器に関連する高コストやSTDに関連する社会的スティグマは、2022年から2029年の予測期間を通じて市場成長の妨げとなります。

世界の性感染症（STD）検査市場の調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、その他の地域です。北米は、有力な市場プレイヤーの存在や、同地域における強固なヘルスケアインフラの利用可能性などの要因から、市場シェアの面で主要な地域となっています。一方、アジア太平洋地域は、STDの有病率の上昇や、政府当局による啓発キャンペーンや償還政策などの有利な施策の増加などの要因により、予測期間中に大きく成長すると予想されます。

本レポートに掲載されている主な市場参入企業は以下のとおりです。

• Abbott Laboratories
• Becton Dickinson Company
• Biomerieux, Inc.
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• Diasorin Molecular Llc
• Hologic Inc.
• Orasure Technologies, Inc.
• Roche Holdings Ag
• Thermo Fisher Scientific（Affymetrix）

市場における最近の開拓。

• 2019年6月、クエスト・ダイアグノスティックス社は、性感染症（STD）の3つの検査パッケージの販売を開始しました。このパッケージは、クラミジア、淋病、梅毒をカバーし、米国全域の個人がオンラインで購入できるようになる予定です。
• 2022年4月、米国のChiricahua Community Health Centers, Inc.（CCHCI）は、The Body Agency Collective（TBAC）およびVisby Medical, Incと、性感染症（STI）の診断と治療を強化する共同事業に参入しました。このプロジェクトでは、コミュニティヘルスセンターがPCR診断装置「Sexual Health Click Test」を活用し、女性のSTIを30分以内に検査することになります。

世界の性感染症（STD）検査市場調査範囲。

過去データ：2019年～2020年～2021年

基本推定年：2021年

予測期間：2022年～2029年

レポート対象収益予測、企業ランキング、競合情勢、成長要因、動向

対象セグメント疾患タイプ、検査場所、地域

地域範囲北米、欧州、アジア太平洋、中南米、その他世界のその他の地域

調査範囲レポートのカスタマイズは無料です（アナリストの作業時間8時間分まで）。国、地域、セグメント範囲*の追加または変更

本調査の目的は、近年における様々なセグメントおよび国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。市場の詳細なセグメントとサブセグメントを以下に説明します。

疾患タイプ別

クラミジア

淋病

単純ヘルペスウイルス

梅毒

ヒトパピローマウイルス（HPV）

ヒト免疫不全ウイルス（HIV）

その他の疾患

検査場所別

ラボラトリーテスト

ポイントオブケア（POC）検査）

地域別

北米

米国

カナダ

欧州

英国

ドイツ

フランス

スペイン

イタリア

その他欧州

アジア太平洋地域

中国

インド

日本

オーストラリア

韓国

その他アジア太平洋

ラテンアメリカ

ブラジル

メキシコ

世界のその他の地域

目次

第1章 エグゼクティブサマリー

• 市場スナップショット
• 世界・セグメント別市場推定・予測、2019-2029年
  • 性感染症（STD）検査市場：地域別、2019-2029年
  • 性感染症（STD）検査市場、疾患タイプ別、2019-2029年
  • 性感染症（STD）検査市場：検査場所別、2019年～2029年
• 主な動向
• 調査手法
• 調査前提条件

第2章 性感染症（STD）検査の世界市場定義と範囲

• 調査の目的
• 市場の定義と範囲
  • 調査対象範囲
  • 産業の進化
• 調査対象年
• 通貨換算レート

第3章 性感染症（STD）検査の世界市場力学

• 性感染症（STD）検査市場のインパクト分析（2019年～2029年）
  • 市場促進要因
    • 世界のSTDの有病率の増加
    • STDに対する有利な診療報酬政策
    • 大手市場プレイヤーの戦略的な取り組み
  • 市場の課題
    • 検査機器に関連する高コスト
    • 性病に関連する社会的スティグマ
  • 市場機会
    • 発展途上地域におけるヘルスケア・インフラの拡大。
    • STDの流行に対する患者の意識の高まり

第4章 世界の性感染症（STD）検査市場の産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
• PEST分析
  • 政治的
  • 経済的
  • 社会的
  • 技術的
• 投資採用モデル
• アナリストの結論・提言
• トップ投資機会
• 主要成功戦略

第5章 リスク評価：COVID-19のインパクト

• COVID-19が業界に与える全体的な影響の評価
• COVID-19以前とCOVID-19以後の市場シナリオ

第6章 性感染症（STD）検査の世界市場、疾患タイプ別

• 市場スナップショット
• 性感染症（STD）検査の世界市場：疾患タイプ別、パフォーマンス-ポテンシャル分析
• 性感染症（STD）検査の世界市場、疾患タイプ別推定・予測2019～2029年
• 性感染症（STD）検査市場、サブセグメント分析
  • クラミジア
  • 淋病
  • 単純ヘルペスウイルス
  • 梅毒
  • ヒトパピローマウイルス（HPV）
  • その他の病気（ヒト免疫不全ウイルス（HIV）、甲状腺腫、トリコモナス、B型肝炎など）

第7章 性感染症（STD）検査の世界市場：検査場所別

• 市場スナップショット
• 性感染症（STD）検査の世界市場：検査部位別、実績-ポテンシャル分析
• 性感染症（STD）検査の世界市場、検査場所別推定・予測：2019-2029年
• 性感染症（STD）検査市場、サブセグメント分析
  • ラボラトリーテスト
  • ポイントオブケア（POC）検査

第8章 性感染症（STD）検査の世界市場：地域別分析

• 性感染症（STD）検査市場、地域別市場スナップショット
• 北米
  • 米国
    • 疾患タイプ別の推定・予測、2019-2029年
    • 検査場所別の推定・予測、2019-2029年
  • カナダ
• 欧州の性感染症（STD）検査市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他の欧州地域
• アジア太平洋地域の性感染症（STD）検査市場のスナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカの性感染症（STD）検査市場のスナップショット
  • ブラジル
  • メキシコ
• 世界のその他の地域

第9章 競合情報

• トップ市場戦略
• 企業プロファイル
  • Abbott Laboratories
    • 主な情報
    • 概要
    • 財務（データの入手が可能な場合）
    • 製品概要
    • 最近の開発状況
  • Becton Dickinson Company
  • Biomerieux, Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Diasorin Molecular LLC
  • Hologic Inc.
  • Orasure Technologies, Inc.
  • Roche Holdings Ag
  • Thermo Fisher Scientific（Affymetrix）

第10章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • バリデーション
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1. Global Sexually Transmitted Diseases (STD) Testing Market, report scope
• TABLE 2. Global Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by Disease Type 2019-2029 (USD Billion)
• TABLE 4. Global Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by Location of Testing 2019-2029 (USD Billion)
• TABLE 5. Global Sexually Transmitted Diseases (STD) Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global Sexually Transmitted Diseases (STD) Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Sexually Transmitted Diseases (STD) Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Sexually Transmitted Diseases (STD) Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Sexually Transmitted Diseases (STD) Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Sexually Transmitted Diseases (STD) Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Sexually Transmitted Diseases (STD) Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Sexually Transmitted Diseases (STD) Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Sexually Transmitted Diseases (STD) Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Sexually Transmitted Diseases (STD) Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. U.S. Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. Canada Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 19. Canada Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. Canada Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. UK Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 22. UK Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. UK Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. Germany Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 25. Germany Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. Germany Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. France Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 28. France Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. France Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. Italy Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 31. Italy Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Italy Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Spain Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 34. Spain Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. Spain Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. RoE Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 37. RoE Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. RoE Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. China Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 40. China Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. China Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. India Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 43. India Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. India Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. Japan Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 46. Japan Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. Japan Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. South Korea Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 49. South Korea Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. South Korea Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. Australia Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 52. Australia Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. Australia Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. RoAPAC Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. Brazil Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 58. Brazil Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Brazil Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Mexico Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 61. Mexico Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. Mexico Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. RoLA Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 64. RoLA Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. RoLA Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. Row Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 67. Row Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. Row Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. List of secondary sources, used in the study of global Sexually Transmitted Diseases (STD) Testing Market
• TABLE 70. List of primary sources, used in the study of global Sexually Transmitted Diseases (STD) Testing Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Sexually Transmitted Diseases (STD) Testing Market, research methodology
• FIG 2. Global Sexually Transmitted Diseases (STD) Testing Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Sexually Transmitted Diseases (STD) Testing Market, key trends 2021
• FIG 5. Global Sexually Transmitted Diseases (STD) Testing Market, growth prospects 2022-2029
• FIG 6. Global Sexually Transmitted Diseases (STD) Testing Market, porters 5 force model
• FIG 7. Global Sexually Transmitted Diseases (STD) Testing Market, pest analysis
• FIG 8. Global Sexually Transmitted Diseases (STD) Testing Market, value chain analysis
• FIG 9. Global Sexually Transmitted Diseases (STD) Testing Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Sexually Transmitted Diseases (STD) Testing Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Sexually Transmitted Diseases (STD) Testing Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Sexually Transmitted Diseases (STD) Testing Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Sexually Transmitted Diseases (STD) Testing Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Sexually Transmitted Diseases (STD) Testing Market, regional snapshot 2019 & 2029
• FIG 15. North America Sexually Transmitted Diseases (STD) Testing Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Sexually Transmitted Diseases (STD) Testing Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Sexually Transmitted Diseases (STD) Testing Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Sexually Transmitted Diseases (STD) Testing Market 2019 & 2029 (USD Billion)
• FIG 19. Global Sexually Transmitted Diseases (STD) Testing Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Sexually Transmitted Diseases (STD) Testing Market is valued approximately USD 96.06 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.1% over the forecast period 2022-2029. Sexually Transmitted Diseases (STD) refer to infection transmitted from an infected person to an uninfected person through sextual contact. STDs are caused by bacteria, and viruses. Chlamydia, Gonorrhea, Herpes Simplex Virus, Syphilis, Human Papillomavirus (HPV), and Human Immunodeficiency Virus among others are different kind of STDs. The increasing prevalence of STDs worldwide and favorable reimbursement policies for STDs as well as strategic initiatives from leading market players are key factors accelerating the market growth.

According to the World Health Organization (WHO) estimates - in 2020, globally around 374 million new cases of STIs were reported. In addition, the most prevalent type of infection was chlamydia with 129 million cases, followed by gonorrhoea with 82 million cases, syphilis with 7.1 million cases and trichomoniasis with 156 million cases. Also, growing healthcare infrastructure in the developing regions and rising patient awareness towards STD prevalence would create lucrative growth prospectus for the market over the forecast period. However, the high cost associated with testing equipment and social stigma associated with STDs impede the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Sexually Transmitted Diseases (STD) Testing Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region in terms of market share due to factors such as presence of leading market players as well as availability of robust healthcare infrastructure in the region. Whereas Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising prevalence of STDs as well as increasing number of favorable initiatives from government authorities in terms of awareness campaigns and reimbursement policies in the region.

Major market players included in this report are:

Abbott Laboratories

Becton Dickinson Company

Biomerieux, Inc.

Bio-Rad Laboratories Inc.

Danaher Corporation

Diasorin Molecular Llc

Hologic Inc.

Orasure Technologies, Inc.

Roche Holdings Ag

Thermo Fisher Scientific (Affymetrix)

Recent Developments in the Market:

• In June 2019, Quest Diagnostics, launched three laboratory testing packages for sexually transmitted diseases (STDs). The package would cover chlamydia, gonorrhea, and syphilis, would be available for online purchase by individuals across the United States.
• In April 2022, USA based Chiricahua Community Health Centers, Inc. (CCHCI) entered in a collaboration with The Body Agency Collective (TBAC) and Visby Medical, Inc., to enhance the diagnosis and treatment of sexually transmitted infection (STI). Under this project the community health center would utilize PCR diagnostic device, the Sexual Health Click Test to test STIs in women within 30 minutes.

Global Sexually Transmitted Diseases (STD) Testing Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered Disease Type, Location of Testing, Region

Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Type

Chlamydia

Gonorrhea

Herpes Simplex Virus

Syphilis

Human Papillomavirus (HPV)

Human Immunodeficiency Virus (HIV)

Other Diseases

By Location of Testing

Laboratory Testing

Point-of-care (POC) Testing)

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Sexually Transmitted Diseases (STD) Testing Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Sexually Transmitted Diseases (STD) Testing Market, by Disease Type, 2019-2029 (USD Billion)
  • 1.2.3. Sexually Transmitted Diseases (STD) Testing Market, by Location of Testing, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Sexually Transmitted Diseases (STD) Testing Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Sexually Transmitted Diseases (STD) Testing Market Dynamics

• 3.1. Sexually Transmitted Diseases (STD) Testing Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing prevalence of STDs worldwide.
    • 3.1.1.2. Favourable reimbursement policies for STDs
    • 3.1.1.3. Strategic initiatives from leading market players.
  • 3.1.2. Market Challenges
    • 3.1.2.1. High cost associated with testing equipment.
    • 3.1.2.2. Social stigma associated with STDs
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing healthcare infrastructure in the developing regions.
    • 3.1.3.2. Rising patient awareness towards STD prevalence.

Chapter 4. Global Sexually Transmitted Diseases (STD) Testing Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Sexually Transmitted Diseases (STD) Testing Market, by Disease Type

• 6.1. Market Snapshot
• 6.2. Global Sexually Transmitted Diseases (STD) Testing Market by Disease Type, Performance - Potential Analysis
• 6.3. Global Sexually Transmitted Diseases (STD) Testing Market Estimates & Forecasts by Disease Type 2019-2029 (USD Billion)
• 6.4. Sexually Transmitted Diseases (STD) Testing Market, Sub Segment Analysis
  • 6.4.1. Chlamydia
  • 6.4.2. Gonorrhea
  • 6.4.3. Herpes simplex virus
  • 6.4.4. Syphilis
  • 6.4.5. Human papillomavirus (HPV)
  • 6.4.6. Other diseases (human immunodeficiency virus (HIV), chancroid, trichomoniasis, and hepatitis B)

Chapter 7. Global Sexually Transmitted Diseases (STD) Testing Market, by Location of Testing

• 7.1. Market Snapshot
• 7.2. Global Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, Performance - Potential Analysis
• 7.3. Global Sexually Transmitted Diseases (STD) Testing Market Estimates & Forecasts by Location of Testing 2019-2029 (USD Billion)
• 7.4. Sexually Transmitted Diseases (STD) Testing Market, Sub Segment Analysis
  • 7.4.1. Laboratory testing
  • 7.4.2. Point of care (POC) testing

Chapter 8. Global Sexually Transmitted Diseases (STD) Testing Market, Regional Analysis

• 8.1. Sexually Transmitted Diseases (STD) Testing Market, Regional Market Snapshot
• 8.2. North America Sexually Transmitted Diseases (STD) Testing Market
  • 8.2.1. U.S. Sexually Transmitted Diseases (STD) Testing Market
    • 8.2.1.1. Disease Type breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. Location of Testing breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada Sexually Transmitted Diseases (STD) Testing Market
• 8.3. Europe Sexually Transmitted Diseases (STD) Testing Market Snapshot
  • 8.3.1. U.K. Sexually Transmitted Diseases (STD) Testing Market
  • 8.3.2. Germany Sexually Transmitted Diseases (STD) Testing Market
  • 8.3.3. France Sexually Transmitted Diseases (STD) Testing Market
  • 8.3.4. Spain Sexually Transmitted Diseases (STD) Testing Market
  • 8.3.5. Italy Sexually Transmitted Diseases (STD) Testing Market
  • 8.3.6. Rest of Europe Sexually Transmitted Diseases (STD) Testing Market
• 8.4. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Snapshot
  • 8.4.1. China Sexually Transmitted Diseases (STD) Testing Market
  • 8.4.2. India Sexually Transmitted Diseases (STD) Testing Market
  • 8.4.3. Japan Sexually Transmitted Diseases (STD) Testing Market
  • 8.4.4. Australia Sexually Transmitted Diseases (STD) Testing Market
  • 8.4.5. South Korea Sexually Transmitted Diseases (STD) Testing Market
  • 8.4.6. Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market
• 8.5. Latin America Sexually Transmitted Diseases (STD) Testing Market Snapshot
  • 8.5.1. Brazil Sexually Transmitted Diseases (STD) Testing Market
  • 8.5.2. Mexico Sexually Transmitted Diseases (STD) Testing Market
• 8.6. Rest of The World Sexually Transmitted Diseases (STD) Testing Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Abbott Laboratories
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Becton Dickinson Company
  • 9.2.3. Biomerieux, Inc.
  • 9.2.4. Bio-Rad Laboratories Inc.
  • 9.2.5. Danaher Corporation
  • 9.2.6. Diasorin Molecular LLC
  • 9.2.7. Hologic Inc.
  • 9.2.8. Orasure Technologies, Inc.
  • 9.2.9. Roche Holdings Ag
  • 9.2.10. Thermo Fisher Scientific (Affymetrix)

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption